Search
Search Results
Found 9 items.
-
Treatment of very old patients with non valvular atrial fibrillation. The valuable opportunity offered by New Oral Anticoagulants, to be cautiously used
Published: December 30, 20131689PDF: 961 -
Direct oral anticoagulants in patients undergoing cardioversion: insight from randomized clinical trials
Published: May 18, 20172420PDF: 1177 -
Efficacy and safety of oral anticoagulant therapy in frail patients with atrial fibrillation
Published: June 7, 20184300PDF: 840 -
Thromboembolic and hemorrhagic risk stratification in patients with atrial fibrillation. Part I: the thromboembolic risk
Published: November 25, 20151104PDF: 703 -
Net clinical benefit of anticoagulation therapy in the elderly patients with atrial fibrillation
Published: June 7, 20183723PDF: 597 -
Thromboembolic and hemorrhagic risk stratification in patients with atrial fibrillation. Part II: hemorrhagic risk and guidelines recommendations
Published: November 25, 20151096PDF: 617 -
Rivaroxaban in non valvular atrial fibrillation: subgroups analysis
Published: August 19, 20151264PDF: 905 -
Critical issues in megatrials on new oral anticoagulants. Rocket AF: applying results to low risk patients
Published: November 25, 2015991PDF: 635 -
From warfarin to new oral anticoagulants in clinical practice. What is the future of anticoagulant therapy in atrial fibrillation?
Published: November 25, 2015749PDF: 697
1 - 9 of 9 items